Showing results (801-810 of 922) with videos related to
Sort By:
Pageof 93
Journal of Neurosurgery. Pediatrics|November 15, 2024
Variations in the management of pediatric cerebral vasospasmNicholas S Szuflita, Silky Chotai, Michael J Feldman, et al.Circulation|May 14, 2003
Incomplete resolution of ST-segment elevation is a marker of transient microcirculatory dysfunction after stenting for acute myocardial infarctionLaurent J Feldman, Pierre Coste, Alain Furber, et al.AIDS and Behavior|October 22, 2014
Unannounced telephone-based pill counts: a valid and feasible method for monitoring adherenceR Fredericksen, B J Feldman, T Brown, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2011
First-in-man study of CPX-351: a liposomal carrier containing cytarabine and daunorubicin in a fixed 5:1 molar ratio for the treatment of relapsed and refractory acute myeloid leukemiaEric J Feldman, Jeffrey E Lancet, Jonathan E Kolitz, et al.Schizophrenia Research|September 18, 2004
The heterogeneity of schizophrenia in disease statesPenny E Mohr, C Michael Cheng, Karl Claxton, et al.Bone Marrow Transplantation|March 1, 1997
Single and double autotransplants for relapsing/refractory Hodgkin's disease: results of two consecutive trialsT Ahmed, D E Lake, M Beer, et al.Oncotarget|September 17, 2017
Vorinostat suppresses hypoxia signaling by modulating nuclear translocation of hypoxia inducible factor 1 alphaChao Zhang, Chunzhang Yang, Michael J Feldman, et al.The American Journal of Cardiology|December 9, 2022
Clinical Significance of Culprit Vessel Occlusion in Patients With Non-ST-Elevation Myocardial Infarction Who Underwent Percutaneous Coronary InterventionBatric Popovic, Gregory Ducrocq, Yedid Elbez, et al.Blood|September 20, 2021
Phase 1/2 study of uproleselan added to chemotherapy in patients with relapsed or refractory acute myeloid leukemiaDaniel J DeAngelo, Brian A Jonas, Jane L Liesveld, et al.Stereotactic and Functional Neurosurgery|March 21, 2024
Global Economic Evaluation of the Reported Costs of Deep Brain StimulationAnthony E Bishay, Alexander T Lyons, Stefan W Koester, et al.Pageof 93